WHO recommendation on advance misoprostol distribution to pregnant women for prevention of postpartum haemorrhage

In settings where women give birth outside of a health facility and in the absence of skilled health personnel, a strategy of antenatal distribution of misoprostol to pregnant women for self-administration is recommended for prevention of postpartum haemorrhage, only with targeted monitoring and evaluation